Table 2.
Optimal number of reference miRNAs – pancreatic cancer
Number of miRNAs | Va | ΔVa | miRNAs added | Stability increased? |
---|---|---|---|---|
2 | – | – | miR-103a-3p, miR-374b-5p | – |
3 vs 2 | 0.1884 | – | miR-361-5p | – |
4 vs 3 | 0.1328 | -0.0556 | let-7 g-5p | yes |
5 vs 4 | 0.1141 | -0.0186 | miR-28-5p | yes |
6 vs 5 | 0.0962 | -0.0179 | miR-29a-3p | yes |
7 vs 6 | 0.0831 | -0.0131 | miR-301a-3p | yes |
8 vs 7 | 0.0631 | -0.0200 | miR-340-5p | yes |
9 vs 8 | 0.0596 | -0.0036 | miR-27a-3p | yes |
10 vs 9 | 0.0522 | -0.0073 | miR-106b-5p | yes |
11 vs 10 | 0.0527 | 0.0005 | miR-152-3p | no |
12 vs 11 | 0.0549 | 0.0021 | miR-26b-5p | no |
13 vs 12 | 0.0464 | -0.0084 | miR-660-5p | yes |
14 vs 13 | 0.0470 | 0.0006 | miR-24-3p | no |
15 vs 14 | 0.0517 | 0.0047 | miR-23b-3p | no |
16 vs 15 | 0.0569 | 0.0052 | miR-199a-3p | no |
MiRNAs in bold are the ones that are included in the optimal number of references to use.
a The stability measure V is calculated according to Vandesompele et al. [21]